by Sarah Wentzel-Fisher, Thornburg Foundation

In New Mexico, the health of forests, headwaters, and aquifers determines whether farmers and ranchers can graze, plant, irrigate and harvest. Wildfire, flood and drought cascade from headwaters into broken acequias and lost crops, undermining the economies and traditions of rural communities. We can’t prevent every storm, but we can reduce their long-term impacts through better stewardship — and we must invest in that resilience through conservation finance.

According to the Conservation Finance Network, conservation finance encompasses the full range of tools that fund and sustain ecological outcomes — from grants and philanthropy to market-based mechanisms such as ecosystem payments, water or carbon credits, and blended-capital investments. In essence, it’s about matching the scale of ecological need with capital models that extend beyond grants and one-time appropriations. In New Mexico, conservation finance becomes especially powerful when it links forest restoration, acequia resilience and groundwater recharge into one hydrologic and financial framework. Water is life here, and we are at a moment of reckoning. Shifting how we value, and finance, water stewardship will determine whether agriculture remains viable in the future.

Conservation finance — with its mix of grants, performance contracts, loans, and private investment — is the bridge between today’s fragmented funding landscape and a more resilient future. When public infrastructure tools and private capital converge to fund the entire hydrologic system — from upland forests to aquifers to acequias — we finally have the architecture to sustain New Mexico’s food systems for the century ahead. In this light, conservation finance is not an environmental luxury or a philanthropic gesture. It is the most practical, immediate strategy for safeguarding the state’s agricultural future — and for ensuring that the rivers, wells, and watersheds that feed New Mexico continue to nourish its people and its economy for generations to come.

Read Sarah’s full article herehttps://greenmoney.com/conservation-finance-as-food-system-infrastructure

 

====

NEW YORK, November 12, 2025 /3BL/ – The Grizzly Bear is the eighth animal featured in Endangered Species Content Series produced by LG Electronics USA in partnership with the National Wildlife Federation (NWF). This awareness campaign, launched in 2024, celebrates the wonder of wildlife, underlines the importance of biodiversity and champions a better future for the planet, all which are at the heart of LG’s “Life’s Good” brand promise.

“Grizzly bears are the guardians of the wild, the living pulse of a healthy ecosystem. As a keystone species, they do not just inhabit the landscape—they create it, balancing wildlife populations and scattering the seeds that become future forests,” said Collin O’Mara, President, and CEO of the National Wildlife Federation. “It is essential for all of us, especially our students, to connect with the wonder of wildlife. We must understand a profound truth: their survival is not separate from ours. Their well-being is our well-being, because when we save wildlife, we save ourselves.”

To inspire a greater connection to the natural world, NWF is inviting students and educators to make a pledge to learn about vulnerable, threatened and endangered species such as grizzly bears. The National Wildlife Federation’s Eco-Schools U.S. program engages students, teachers, and parents in over 6,000 schools in all 50 states – encouraging students to form an action team, design solution-based action projects and measure impact.

Endangered species pledges received through Jan. 15, 2026 will be eligible for prize drawing (subject to the terms and conditions). The student grand prize is the LG 4K Ultra HS short-throw projector (model PU615U) and the educator grand prize is the LG 32-inch smart “Swing Monitor” (model 32U889SA).

The ongoing collaboration with NWF marks another step in LG’s commitment to create a “Better Life for All” and elevates awareness and support for youth lead initiatives, according to LG Electronics USA’s Director of Corporate Marketing Jeannie Lee. “Carrying forward the Life’s Good philosophy, we value our partnership with the National Wildlife Federation, which has a long history of conserving our wildlife and wild places,” she said.

Grizzly bears are featured on LG’s 3D anamorphic billboard in Times Square starting in November. To learn more about these threatened species and how to help safeguard them, read NWF’s blog spotlighting the grizzly bear’s unique behavioral insights and the species’ ecological role. Students and nature enthusiasts can also test their knowledge through an interactive quiz designed to foster a deeper understanding of the species.

Visit www.lg.com/us/sustainability to learn more about LG’s commitment to conservationism and environmental stewardship.

###

Contacts:

LG Electronics North America 
John I. Taylor 
+1 202 719 3490 
john.taylor@lge.com

LG Electronics USA
Laura Barbieri 
laura.barbieri@lge.com
+1 631 848 9818

KENNESAW, Ga.–(BUSINESS WIRE)–Yamaha Rightwaters will repower and support The University of Georgia’s® (UGA®) Marine Extension and Georgia Sea Grant fleet, which works to improve the environmental, social and economic health of the Georgia coast through research, education and extension, over a 5-year period. Yamaha Rightwaters recently provided three Yamaha 150-horsepower outboards in 2025 and will continue to provide outboard power in 2026 and 2027 with one Yamaha 90-horsepower outboard, on

  • Euro-denominated trading under ticker K0Q complementing current Canadian & U.S. listings
  • Enhances capital market platform and access for European investors via local brokerage platforms and market hours
  • Further expansion into the European investor base with a view to accessing strategic partnerships in the region for the

    FCL-X™

    product portfolio

TORONTO, Nov. 12, 2025 /PRNewswire/ – Full Circle Lithium Corp. (“FCL” or the “Company”) (TSXV: FCLI) (OTCQB: FCLIF), a US-based lithium-ion battery fire extinguishing products manufacturer, is excited to announce is pleased to announce that its common shares have commenced trading on the Börse Frankfurt under ticker K0Q, WKN: A3ECHK, ISIN: CA3599171012, providing a euro-denominated access point for European investors. The Company will continue to trade on the TSX Venture Exchange (“TSXV”) under FCLI and on the OTC market under FCLIF. No new shares are being issued, and the capital structure remains unchanged.

The Börse Frankfurt listing simplifies participation for European investors by offering euro-denominated trading through local brokerage platforms and during market hours. This new listing strengthens FCL’s presence in the EU capital markets, enhances global visibility, and supports the Company’s strategy to expand its investor base in sustainability-driven regions. In addition, FCL is actively pursuing strategic partnerships across Europe in the AI-enhanced Battery Energy Storage Systems (AI BESS), automotive, and first responder sectors. These efforts aim to incorporate FCL’s lithium battery fire suppression FCL-X™ technologies into next-generation BESS units, emergency response solutions, used in energy storage facilities, electric vehicle infrastructure, and battery logistics operations.

“Our listing on Börse Frankfurt marks a pivotal milestone in Full Circle Lithium’s growth trajectory,” said Carlos Vicens, CEO of Full Circle Lithium Corp. “Europe leads the world in clean energy adoption and technology innovation. This listing enables us to engage directly with forward-thinking investors and potential partners in the heart of the global energy transition.”

Innovation and Intellectual Property Expansion in the European Union

To further strengthen its European footprint, Full Circle Lithium plans to file new patent applications in the European Union (including Germany) in late 2025 or early 2026, covering advancements in lithium-ion battery fire containment systems, eco-friendly extinguishing compounds, and AI-integrated safety monitoring technologies. These filings will complement FCL’s existing North American, South Korean, and Japanese intellectual property portfolio and reinforce its position as a global leader in lithium battery safety innovation.

Research Update

FCL is pleased to announce it has engaged, subject to regulatory and TSXV approval, the services of Atrium Research Corporation (“Atrium”), a leading company-sponsored research firm. Atrium will publish various research reports on the Company based on based on publicly available information, industry data, and discussions with management. Atrium will also host three recorded interviews with the Company’s management team to present the investment case in an interview format. In exchange for its research services, Atrium will receive cash compensation in the amount of $3,500 per month for the services listed above. The services commenced on November 1, 2025, and will be provided for 12 months.

Marketing Update

FCL has, subject to regulatory and TSXV approval, retained Venture Liquidity Providers Inc. (VLP) to initiate its market-making service to provide assistance in maintaining an orderly trading market for the common shares of the Company.

The market-making service will be undertaken by VLP through a registered broker, W.D. Latimer Co. Ltd., in compliance with the applicable policies of the TSX Venture Exchange and other applicable laws. For its services, the FCL has agreed to pay VLP CAD $5,000 per month for a period of 12 months. The agreement may be terminated at any time by FCL or VLP. The Company and VLP act at arm’s length, and VLP has no present interest, directly or indirectly, in FCL or its securities. The finances and the shares required for the market-making service are provided by W.D. Latimer. The fee paid by FCL to VLP is for services only.  VLP is a specialized consulting firm based in Toronto, providing a variety of services focused on TSX-V-listed issuers. The services commenced on November 4, 2025.

About Full Circle Lithium Corp.

FCL is a U.S.-based lithium products manufacturer focused on sustainable solutions for the lithium and battery safety sector. Its flagship product innovation, FCL-X™, is a proprietary, non-hazardous, water-based fire-extinguishing agent designed specifically to combat the growing threat of lithium-ion battery fires. Backed by a world-class technical team, FCL is committed to delivering safe, effective, and environmentally responsible fire mitigation technologies.

For more information:
Carlos Vicens – CEO & Director
Email: ir@fullcirclelithium.com
Phone: +1.416.977.3832

Cautionary Statement 

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements within the meaning of securities legislation in Canada, and which are based on the expectations, estimates, and projections of management of the parties as of the date of this news release, unless otherwise stated. Forward-looking statements are generally identifiable by use of the words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “ongoing”, “may”, “will”, “project”, “should”, “could”, “believe”, “plans”, “intends” or the negative of these words or other variations on these words or comparable terminology. More particularly, and without limitation, this news release contains forward-looking statements and information concerning expectations on the effectiveness of the marketing and sales of 

FCL-X™

through distribution agreements, the viability, effectiveness, safety and additional commercialization related to

FCL-X™

which is at an early stage of commercialization (which is very difficult for a start-up venture like FCL as there are much larger and better capitalized established companies that can potentially quickly enter the lithium-ion battery fire-fighting market and create strong competition against FCL), on receiving patent protection for

FCL-X™

and related inventions and processes, the ability of FCL, a start-up venture, to successfully commercialize its

FCL-X™

including ramping-up production of the agent to meet potential demand, continue raising capital, upgrading and refurbishing its plant, and sourcing feedstock for this and its other lines of business. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, the uncertainties and risk factors related to the loss of key technical and other staff, the battery fire-extinguishing agent functioning as expected to meet safety requirements and fire-fighting related government regulations and potential client product specifications, and applicable environmental requirements and issues – see additional risks described in FCL’s public filings. Actual results, developments and timetables could vary significantly from the estimates presented. Readers are cautioned not to put undue reliance on forward-looking statements. FCL disclaims any intent or obligation to update publicly such forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law. Additionally, FCL undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of FCL, its financial or operating results or its securities.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/full-circle-lithium-lists-on-borse-frankfurt-to-expand-european-investor-access-302612905.html

SOURCE Full Circle Lithium Inc

Originally published by The Robert A. Winn Excellence in Clinical Trials Award Program

The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards) recently announced 79 new physician-researchers from across the United States have been selected to join the fifth annual cohort of the Winn Career Development Award (Winn CDA) program, a rigorous two-year curriculum designed to advance community-focused clinical research.

The Winn Awards – a national program out of VCU Massey Comprehensive Cancer Center established by the Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization, and also funded by Gilead Sciences, Amgen, and Genentech – exists to address one of medicine’s most persistent challenges: ensuring that all patients, particularly those not typically enrolled in research, benefit from cutting-edge science. Its mission is to improve participation in clinical studies so that treatments developed are tested, safe, and effective for all who will use them, and that people in hard-to-reach communities have better access to the latest advances in medicine.

The Winn Awards accomplishes this by implementing programs to train and educate a national network of community-oriented clinical trialists. The two-year Winn CDA program is the only program of its kind that provides rigorous training in both clinical trial design and implementation as well as the science of community engagement. Each scholar receives a two-year, $240,000 award that secures protected time to pursue research, deepen community partnerships, and advance clinical trial access – all while continuing to care for patients in the communities they serve.

Currently, the program’s research areas include cancer, cardiovascular disease and immunologic disorders. Through an intensive experience that blends research, formal instruction, mentorship, hands-on experience, in-depth workshops, annual convenings, and a capstone project, Winn CDA scholars become experts in conducting community-oriented trials that achieve maximum generalizability through superior recruitment, enrollment, and retention – particularly in communities that historically have low participation in clinical studies.

The new Winn CDA cohort will convene in Albuquerque, New Mexico in November for a 4.5-day workshop on the design and implementation of clinical trials developed with the American Association for Cancer Research (AACR), an organization that has partnered with Winn Awards since the program was founded.

“The Winn Awards embody the spirit of collaboration and commitment that is essential to advancing cancer science for the benefit of all people,” said Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR). “The AACR is honored to partner with this important program to help train and empower the next generation of physician-scientists who are designing and leading clinical trials that reach diverse patient populations. We are deeply committed toward seeing the goal of this vital work become a reality.”

Industry Collaborating for the Greater Good

The Winn Awards program was founded in 2020 with a $100 million commitment from the BMS Foundation. Since its inception, three more funding partners have joined this mission: Gilead Sciences, Amgen, and Genentech. They are united in their commitment to advancing the Winn Awards mission of Better Science for All: transforming the clinical research landscape to ensure that scientific breakthroughs benefit every community.

“It is remarkable to see so many partners across industry and academics come together to tackle this major problem in healthcare,” said Dr. Robert A. Winn, the program’s namesake and Director of VCU Massey Comprehensive Cancer Center. “So much progress has been made in medical research in the last few decades, but clinical trials must include people from all communities in order to ensure that the treatments are effective for everyone. That includes people in rural areas that health care facilities don’t quite reach. We want to make sure the science serves everyone, especially those who are often forgotten or left out of the conversation.” 

“When we launched the Winn Awards five years ago, our goal was to empower a new generation of clinical trialists to bridge the gaps between cutting-edge research and the communities too often left out of advances in medical innovation. With their deep commitment to community-oriented research and their determination to ensure everyone can access the best possible treatments, this year’s tremendous class of Winn CDA scholars reflects that vision in action,” said Catharine Grimes, president of the Bristol Myers Squibb Foundation. “The Bristol Myers Squibb Foundation is proud to support these talented physician-researchers, and we look forward to seeing the continued impact of their work in the communities they serve.”

“Advancing medical research and driving community engagement requires collaboration,” said Michael Levy, SVP, Medical Affairs and Regulatory Affairs, Patient Safety & Quality at Gilead Sciences. “The Winn Awards program has brought together partners from across the industry to tackle a shared mission, and Gilead is proud to be part of this effort. By supporting the next generation of physician-researchers, we are helping to break down barriers to participation and build a stronger future for healthcare that benefits all communities.”

“At Amgen, we believe the future of healthcare depends on ensuring that innovation reaches every patient,” said Ponda Motsepe-Ditshego, vice president, Inclusive Global Health and Impact, Amgen. “The Winn Awards program reflects this vision by investing in healthcare professionals who truly represent the communities we serve. By supporting this initiative, we are not only addressing long-standing barriers in clinical trials but also building a foundation for scientific discoveries that will deliver better outcomes for generations to come. This is how we shape a future where breakthrough medicines improve and extend lives across all communities.”

“Genentech is proud to support the Winn Awards, advancing our shared mission to transform clinical research and ensure it is inclusive for all patients,” said LaVanya Hardin-Wright, Head of Giving & Social Impact, Genentech. “This program is uniquely positioned to train physician-researchers to engage communities who experience barriers to participating in clinical trials. We look forward to championing these scholars as they develop innovative, patient-centered approaches that will improve the future of medicine for everyone.”

The Winn CDA program is more than a training initiative; it is a catalyst for change. By equipping scholars to become transformative leaders in both patient care and research, it is forging a future where communities historically left out of clinical trials are meaningfully engaged. These scholars are redefining how patients are recruited, enrolled, and retained, creating a model of research that is more impactful.

Meet Cohort 5 of the Winn Career Development Award Program

This year, the Winn CDA program received a record 243 applications, a testament to the quality of the program. The 79 physician awardees represent 43 different healthcare institutions in 23 states across the U.S., plus the District of Columbia. They were selected by an independent national review committee made up of prestigious healthcare leaders from organizations throughout the nation. 

The physician-researchers selected are committed to improving participation in research and represent varied perspectives and therapeutic areas, including cancer (hematologic or solid tumors), immunologic disorders, and cardiovascular diseases.

The scholars selected for cohort five of the Winn CDA program are listed below. You can also read their biographies in the 2025 Winn CDA Cohort 5 Bio Book.

  • Ash Alpert, MD, MFA, ScM | Funded by The Bristol Myers Squibb Foundation | Yale Cancer Center
  • Chidinma Anakwenze, MD, MPH | Funded by Gilead Sciences | The University of Texas MD Anderson Cancer Center
  • Anna Arroyo, MD | Funded by The Bristol Myers Squibb Foundation | Stanford University School of Medicine
  • Adanma Ayanambakkam, MBBS, MS | Funded by The Bristol Myers Squibb Foundation | University of Oklahoma Health Stephenson Cancer Center
  • Priscila Barreto Coelho, MD | Funded by Gilead Sciences | Sylvester Comprehensive Cancer Center – University of Miami
  • Felipe Batalini, MD | Funded by Gilead Sciences | Mayo Clinic
  • Adam Berman, MD, MPH | Funded by The Bristol Myers Squibb Foundation | NYU Langone Health / NYU Grossman School of Medicine
  • Teresa Boitano, MD | Funded by Gilead Sciences | University of Alabama at Birmingham
  • Christopher Cann, MD | Funded by The Bristol Myers Squibb Foundation | The Research Institute of Fox Chase Cancer Center
  • Ayushi Chauhan, MD | Funded by The Bristol Myers Squibb Foundation | The University of Texas MD Anderson Cancer Center
  • Kelly Chien, MD | Funded by The Bristol Myers Squibb Foundation | The University of Texas MD Anderson Cancer Center
  • Dai Chihara, MD, PhD | Funded by The Bristol Myers Squibb Foundation | The MD Anderson Cancer Center
  • Nirmal Choradia, MD | Funded by The Bristol Myers Squibb Foundation | Oklahoma University Health Sciences Center
  • Janice Chyou, MD, FACC, FAHA, FHRS | Funded by The Bristol Myers Squibb Foundation | Icahn School of Medicine at Mount Sinai
  • Jordan Ciuro, MD | Funded by The Bristol Myers Squibb Foundation | Emory University
  • Virginia Corbett, MD | Funded by The Bristol Myers Squibb Foundation | Icahn School of Medicine at Mount Sinai
  • Malamo Countouris, MD | Funded by The Bristol Myers Squibb Foundation | University of Pittsburgh Medical Center
  • Glenda Delgado Ramos, MD | Funded by The Bristol Myers Squibb Foundation | University of Texas Southwestern
  • Mary Carter Denny, MD, MPH | Funded by The Bristol Myers Squibb Foundation | Georgetown University School of Medicine
  • Edward Duran, MD, MSc | Funded by Amgen | University of California, San Diego
  • Caitlin Elgarten, MD | Funded by The Bristol Myers Squibb Foundation | University of Pennsylvania, Perelman School of Medicine; Children’s Hospital of Philadelphia
  • Ahmed Elkhanany, MD | Funded by Gilead Sciences | Baylor College of Medicine
  • Oluwadunni Emiloju, MD, MSc | Funded by Genentech | Emory University
  • Fatima Ezzeddine, MD | Funded by Amgen | Mayo Clinic (RST)
  • Dan Feng, MD, PhD | Funded by The Bristol Myers Squibb Foundation | Icahn School of Medicine at Mount Sinai
  • Cristina Fernandez, MD, MPH | Funded by The Bristol Myers Squibb Foundation | Columbia University Vagelos College of Physicians and Surgeons
  • Nicole Fleege, MD | Funded by The Bristol Myers Squibb Foundation | University of Iowa Health Care
  • Luis Gonzalez Castro, MD, PhD | Funded by Genentech | Brigham and Women’s Hospital / Mass General Brigham
  • Jesus Gonzalez Lugo, MD | Funded by The Bristol Myers Squibb Foundation | University of Kansas Cancer Center
  • Parneet Grewal, MBBS | Funded by The Bristol Myers Squibb Foundation | Medical University of South Carolina
  • Nitya Gulati, MBBS, FAAP | Funded by The Bristol Myers Squibb Foundation | Weill Cornell Medicine
  • Andrew Hantel, MD, MPH | Funded by The Bristol Myers Squibb Foundation | Dana-Farber Cancer Institute
  • Omar Harfouch, MD, MPH | Funded by The Bristol Myers Squibb Foundation | University of Maryland Baltimore – School of Medicine
  • Shariska Harrington, MD | Funded by Gilead Sciences | Mayo Clinic
  • Sara Hassani, MD, MHS, MSCR | Funded by The Bristol Myers Squibb Foundation | Northwestern University
  • Ryan T. Hughes, MD | Funded by Genentech | Atrium Health Wake Forest Baptist Comprehensive Cancer Center
  • Chigozirim Izeogu, MD | Funded by Amgen | University of Texas Health Sciences Center at Houston
  • Nusrat Jahan, MBBS | Funded by The Bristol Myers Squibb Foundation | University of Alabama at Birmingham
  • So Yeon Kim, MD | Funded by Gilead Sciences | Yale University
  • Stephen Kimani, MD, MSc | Funded by Gilead Sciences | University of North Carolina at Chapel Hill
  • Kelsey Lau-Min, MD, MSCE | Funded by Genentech | Massachusetts General Hospital
  • Linda-Marie Lavenburg, DO | Funded by The Bristol Myers Squibb Foundation | University of Pittsburgh
  • Jesus Luevano Jr., MD | Funded by The Bristol Myers Squibb Foundation | Morehouse School of Medicine
  • Shalini Makawita, MD | Funded by The Bristol Myers Squibb Foundation | Baylor College of Medicine
  • Adel Mandl, MD, PhD | Funded by Genentech | Johns Hopkins University
  • Anastasia Martynova, MD | Funded by Gilead Sciences | University of Southern California
  • Lisa McElroy, MD, MS | Funded by The Bristol Myers Squibb Foundation | Duke University
  • Sayeef Mirza, MD, MPH, FACP | Funded by The Bristol Myers Squibb Foundation | Moffitt Cancer Center
  • Chemtai Mungo, MD, MPH | Funded by Genentech | University of North Carolina at Chapel Hill
  • Charles (Nate) Nessle, DO | Funded by The Bristol Myers Squibb Foundation | University of Michigan
  • Evangelos Oikonomou, MD, PhD | Funded by Amgen | Yale School of Medicine
  • Zulfa Omer, MBBS | Funded by The Bristol Myers Squibb Foundation | University of Cincinnati
  • Charity Oyedeji, MD | Funded by The Bristol Myers Squibb Foundation | Duke University
  • Aliyah Pabani, MD, MPH | Funded by The Bristol Myers Squibb Foundation | Johns Hopkins University
  • Debanjan Pain, MD, MSCE | Funded by The Bristol Myers Squibb Foundation | The University of Texas MD Anderson Cancer Center
  • Krupal Patel, MD, MSc | Funded by The Bristol Myers Squibb Foundation | City of Hope
  • Hyma V. Polimera, MD | Funded by The Bristol Myers Squibb Foundation | The Pennsylvania State University, College of Medicine
  • Odayme Quesada, MD, MHS, FACC, FAHA, FESC | Funded by The Bristol Myers Squibb Foundation | The Christ Hospital
  • Nicolette Juliana Rodriguez, MD, MPH | Funded by The Bristol Myers Squibb Foundation | Brigham and Women’s Hospital
  • Jose Rubio, MD | Funded by The Bristol Myers Squibb Foundation | University of Alabama at Birmingham
  • Elizabeth Sakach, MD | Funded by The Bristol Myers Squibb Foundation | Emory University
  • Stephanie Samuels, MD | Funded by The Bristol Myers Squibb Foundation | Yale University
  • Caner Saygin, MD | Funded by The Bristol Myers Squibb Foundation | The University of Chicago
  • Michelle Schoettler, MD | Funded by The Bristol Myers Squibb Foundation | Emory University/Children’s Healthcare of Atlanta
  • Senthil Selvaraj, MD, MS, MA | Funded by The Bristol Myers Squibb Foundation | Duke University
  • Tarsheen Sethi, MD, MSc | Funded by The Bristol Myers Squibb Foundation | Yale School of Medicine
  • Arthi Sridhar, MD | Funded by Gilead Sciences | UT Southwestern Medical Center
  • Sara Stockman, MD, PhD | Funded by The Bristol Myers Squibb Foundation | Massachusetts General Hospital
  • Shivani Sud, MD | Funded by The Bristol Myers Squibb Foundation | University of North Carolina at Chapel Hill School of Medicine
  • LaKesha Tables, MD, MPH | Funded by Amgen | Morehouse School of Medicine
  • Lisa May Ling Tachiki, MD | Funded by The Bristol Myers Squibb Foundation | University of Washington/Fred Hutch Cancer Center
  • Kekoa Taparra, MD, PhD, MPH | Funded by Genentech | University of California, Los Angeles
  • Yun Kyoung (Claire) Tiger, MD, PhD | Funded by The Bristol Myers Squibb Foundation | Mayo Clinic Rochester
  • Mazie Tsang, MD, MAS, MS | Funded by The Bristol Myers Squibb Foundation | Mayo Clinic Arizona
  • Samuel Urrutia Argueta, MD | Funded by The Bristol Myers Squibb Foundation | Washington University School of Medicine
  • Manu Varma, DO | Funded by Amgen | NYU Grossman School of Medicine
  • Maria Velez Velez, MD | Funded by Genentech | UCLA Health
  • Moneeza Walji, MD, MPH | Funded by The Bristol Myers Squibb Foundation | Memorial Sloan Kettering Cancer Center
  • Austin Williams, MD, MSEd, FACS | Funded by Gilead Sciences | The Research Institute of Fox Chase Cancer Center
     

Visit www.winnawards.org for more information.
 

Double the beef, bold new flavors, and a playful challenge to competitors—Carl’s Jr. answers consumers’ demand for bigger, better deals

FRANKLIN, Tenn., Nov. 12, 2025 /PRNewswire/ — As inflation and shrinkflation reshape America’s dining landscape, consumer behavior shows diners are seeking deals at an unprecedented rate. Carl’s Jr.® is stepping up to meet this demand with the all-new Cali XL burger—offering guests double the beef of the Big Mac for just $5.99—and a can’t miss “Sad Mac Buy Back” campaign daring burger lovers to make the switch.

“People want a burger that’s actually worth it. Our new Cali XL has more meat, more flavor and more value,” said Paz Romero, vice president of brand at Carl’s Jr. “The ‘Sad Mac Buy Back’ is our way of letting guests try it for themselves by swapping disappointment for something better— no questions asked.”

The “Sad Mac Buy Back”: A Bold Burger Swap

From November 12-21, Carl’s Jr. is inviting fans to swap their old Golden Arches receipt for something bigger, bolder and better – a free Cali XL loaded directly into their My Rewards account. To claim, guests simply upload a photo of any McDonald’s burger receipt dated between January 1 and November 11, 2025 at carlsjr.com/sadmacbuyback. Guests who qualify will receive their free Cali XL reward beginning November 22. The launch is backed by TV spots and a social campaign sending a clear message to burger lovers everywhere: “More meat. More flavor. More value.”

Cali XL: Value and Size That Stand Out

Available now for a limited time, the Cali XL stacks two 3.5oz charbroiled beef patties (7oz total; pre-cooked weight), double American cheese, grilled onions, Classic Sauce, lettuce and tomato on a seeded bun. At $5.99, it offers burger lovers twice the beef of industry leaders, verified by independent and internal experts.

For even more savings, guests can enjoy a Cali XL combo – complete with natural-cut fries and an ice-cold Coke®—for just $2 more.

Free Cali XL Burger Offer Terms
*Claim your free Cali XL Burger today. ‘Sad Mac Buy Back’ promotion valid November 12, 2025 until November 21, 2025 at participating restaurants only. Must submit proof of McDonald’s® burger purchase between January 1, 2025-November 11, 2025 to qualify. Offer available only to registered My Rewards members. Promotion redeemable in the app, at order.carlsjr.com, or in-restaurant. Redemption in restaurant by scanning the offer redemption QR code from the Carl’s Jr. app before providing payment to cashier. Limit one redemption per registered user. 599 free burgers to be given away. Not valid for use within a combo or in combination with any other offer or discount. Offer not available for redemption with 3rd party vendors or delivery partners. Exclusions may apply. Subject to cancellation at any time. © 2025 Carl’s Jr. Restaurants LLC. $5.99 offer valid until January 21, 2026. All rights reserved.

My Rewards Loyalty Program: 

Join here


Twitter: 
@CarlsJr

Instagram: 
@carlsjr

TikTok: @carlsjrofficial
Facebook: https://www.facebook.com/carlsjr/ 

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/carls-jr-heats-up-value-wars-with-new-cali-xl-burger-and-sad-mac-buy-back-302612481.html

SOURCE CKE Restaurants Holdings, Inc.

NEWARK, Calif., Nov. 12, 2025 /PRNewswire/ — Lucid Group, Inc. (Nasdaq: LCID) today announced the pricing of its offering of $875,000,000 aggregate principal amount of 7.00% convertible senior notes due 2031 in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The issuance and sale of the notes are scheduled to settle on or about November 17, 2025, subject to the satisfaction of customary closing conditions. Lucid also granted the initial purchasers of the notes an option, for settlement within a period of 13 days from, and including, the date the notes are first issued, to purchase up to an additional $100,000,000 principal amount of notes.

The Notes

The notes will be senior, unsecured obligations of Lucid and will accrue interest at a rate of 7.00% per annum, payable semi-annually in arrears on May 1 and November 1 of each year, beginning on May 1, 2026. The notes will mature on November 1, 2031, unless earlier repurchased, redeemed or converted. Before August 1, 2031, noteholders will have the right to convert their notes only upon the occurrence of certain events and during specified periods. From and after August 1, 2031, noteholders may convert their notes at any time at their election until the close of business on the second scheduled trading day immediately before the maturity date. Lucid will settle conversions of notes by paying or delivering, as applicable, cash, shares of its Class A common stock, or a combination thereof, at Lucid’s election. The initial conversion rate is 48.0475 shares of common stock per $1,000 principal amount of notes, which represents an initial conversion price of approximately $20.81 per share of common stock. The initial conversion price represents a premium of approximately 22.5% over the last reported sale price on The Nasdaq Global Select Market of $16.99 per share of Lucid’s common stock on November 11, 2025. The conversion rate and conversion price will be subject to adjustment upon the occurrence of certain events. If a “make-whole fundamental change” (as defined in the indenture for the notes) occurs, Lucid will, in certain circumstances, increase the conversion rate for a specified time for holders who convert their notes in connection with that make-whole fundamental change.

The notes will be redeemable, in whole or in part (subject to certain limitations), for cash at Lucid’s option at any time, and from time to time, on or after November 6, 2028 and on or before the 31st scheduled trading day immediately before the maturity date, but only if the last reported sale price per share of Lucid’s common stock exceeds 130% of the conversion price for a specified period of time and certain liquidity conditions are satisfied. The redemption price will be equal to the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. If Lucid calls any or all notes for redemption, holders of notes called for redemption may convert their notes during the related redemption conversion period, and any such conversion will also constitute a “make-whole fundamental change” with respect to the notes so converted.

Noteholders may require Lucid to repurchase their notes on November 1, 2029 at a cash repurchase price equal to the principal amount of the notes to be repurchased. In addition, if a “fundamental change” (as defined in the indenture for the notes) occurs, then, subject to limited exceptions, holders may require Lucid to repurchase their notes for cash. The repurchase price will be equal to the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the applicable repurchase date.

Lucid estimates that the net proceeds from the offering will be approximately $863.5 million (or approximately $962.4 million if the initial purchasers fully exercise their option to purchase additional notes), after deducting the initial purchasers’ discounts and commissions and estimated offering expenses. Lucid intends to use approximately $752.2 million of the net proceeds from the offering to fund repurchases of approximately $755.7 million aggregate principal amount of its outstanding 1.25% Convertible Senior Notes due 2026. Lucid intends to use the remaining net proceeds for general corporate purposes.

Repurchases of Outstanding 2026 Notes

Concurrently with the pricing of the notes, Lucid entered into one or more separate and individually negotiated transactions with certain holders of the 2026 notes to repurchase for cash a portion of the 2026 notes on terms negotiated with each such holder.

Ayar Prepaid Forward Transaction

In connection with the pricing of the notes, Ayar Third Investment Company (“Ayar”), a wholly-owned subsidiary of PIF, entered into a privately negotiated prepaid forward transaction with a forward counterparty that is an affiliate of one of the initial purchasers, pursuant to which Ayar will purchase approximately $636.7 million of Lucid’s common stock (based on the last reported sale price on The Nasdaq Global Select Market of $16.99 per share of Lucid’s common stock on November 11, 2025) with delivery expected to occur on or about the maturity date for the notes, subject to the ability of the forward counterparty to elect to settle all or a portion of the prepaid forward transaction early. Subject to the conditions set forth in the agreement governing the prepaid forward transaction, the prepaid forward transaction will be settled physically, subject to Ayar’s option to elect cash settlement of the prepaid forward transaction. Lucid is not a party to the prepaid forward transaction.

The prepaid forward transaction is generally intended to facilitate privately negotiated derivative transactions, including swaps, between the forward counterparty or its affiliates and investors in the notes relating to Lucid’s common stock by which investors in the notes will hedge their investments in the notes. Ayar’s entry into the prepaid forward transaction with the forward counterparty and the entry by the forward counterparty into derivative transactions in respect of Lucid’s common stock with the investors of the notes could have the effect of increasing (or reducing the size of any decrease in) the market price of Lucid’s common stock concurrently with, or shortly after, the pricing of the notes and effectively raising the initial conversion price of the notes.

Additional information about the transactions described in this press release can be found in the Current Report on Form 8-K that Lucid intends to file with the Securities and Exchange Commission on or about November 17, 2025.

The offer and sale of the notes and any shares of Lucid’s common stock issuable upon conversion of the notes have not been, and will not be, registered under the Securities Act or any other securities laws, and the notes and any such shares cannot be offered or sold except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any other applicable securities laws. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, the notes or any shares of Lucid’s common stock issuable upon conversion of the notes, nor will there be any sale of the notes or any such shares, in any state or other jurisdiction in which such offer, sale or solicitation would be unlawful.

About Lucid Group

Lucid (NASDAQ: LCID) is a Silicon Valley-based technology company focused on creating the most advanced EVs in the world. The award-winning Lucid Air and Lucid Gravity SUV deliver best-in-class performance, sophisticated design, expansive interior space and unrivaled energy efficiency. Lucid assembles both vehicles in its state-of-the-art, vertically integrated factories in Arizona and Saudi Arabia. Through its industry-leading technology and innovations, Lucid is advancing the state-of-the-art of EV technology for the benefit of all.

Investor Relations Contact

investor@lucidmotors.com

Media Contact

media@lucidmotors.com

Forward-Looking Statements

This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “shall,” “expect,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the completion of the offering and the expected amount and intended use of the net proceeds. Actual events and circumstances may differ from these forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties. Among those risks and uncertainties are market conditions, the satisfaction of the closing conditions related to the offering and risks relating to Lucid’s business, including those factors discussed under the cautionary language and the Risk Factors in Lucid’s Annual Report on Form 10-K for the year ended December 31, 2024, subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other documents Lucid has filed or will file with the Securities and Exchange Commission. If any of these risks materialize or Lucid’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Lucid currently does not know or that Lucid currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. Lucid may not consummate the offering described in this press release and, if the offering is consummated, cannot provide any assurances regarding its ability to effectively apply the net proceeds as described above. In addition, forward-looking statements reflect Lucid’s expectations, plans or forecasts of future events and views as of the date of this communication. Lucid anticipates that subsequent events and developments will cause Lucid’s assessments to change. However, while Lucid may elect to update these forward-looking statements at some point in the future, Lucid specifically disclaims any obligation to do so. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-group-inc-prices-875-000-000-convertible-senior-notes-offering-302612861.html

SOURCE Lucid Group

This recognition underscores Delta’s market leadership, innovation, and customer-centric strategy in advancing integrated energy systems across Europe.

SAN ANTONIO, Nov. 12, 2025 /PRNewswire/ — Frost & Sullivan is pleased to announce that Delta Electronics (Delta) has been given the 2025 Europe Company of the Year Recognition in the integrated energy solutions industry for its strong overall performance in driving innovation, customer value, and sustainable growth. This highlights Delta’s consistent leadership in shaping the transition toward a cleaner and more resilient energy future through its comprehensive portfolio of power, automation, and grid technologies.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Delta excelled in both, demonstrating the ability to align its innovation roadmap with urgent market needs such as renewable integration, energy storage, and EV infrastructure, while executing these strategies with speed, precision, and scalability. “Delta has positioned itself as a trusted partner in the energy transition by transforming complex challenges such as grid congestion, deployment delays, and regulatory uncertainties into customer-centric solutions that are modular, intelligent, and future-ready,” said Neha Tatikota, senior industry analyst at Frost & Sullivan.

Guided by a forward-looking growth strategy, Delta continues to expand its presence across high-potential markets, particularly in Central and Western Europe, where progressive policy frameworks and accelerating electrification drive demand for holistic energy ecosystems. With end-to-end solutions spanning PV inverters, battery energy storage systems (BESS), EV charging infrastructure, microgrids, and the AI-enabled DeltaGrid® energy management platform, Delta addresses both immediate market requirements and long-term sustainability goals.

Innovation is central to Delta’s approach. Its Energy Storage Solution M and C Series, designed for utility-scale and space-constrained applications, respectively, embody the company’s modular and scalable philosophy. Complementing this, Delta’s Ultra Fast Charger 500 kW and DC Wallbox 50 kW exemplify how the company anticipates user-centric needs while supporting grid integration. By combining energy storage, renewables, and EV charging under an intelligent management platform, Delta empowers clients to deploy integrated systems with agility and measurable value. “We are incredibly proud to be recognized by Frost & Sullivan for this achievement,” said Rakesh Mukhija, Head of Power & Energy Solutions at Delta EMEA. “This award is a testament to our team’s relentless dedication and the trust our customers and partners place in our solutions. It validates our long-term commitment to advancing clean energy infrastructure and supporting Europe’s ambitious decarbonization goals.”

Delta’s customer-first mindset extends beyond product delivery into consultative engagement and tailored deployment models. Its phased investment approach allows clients to start with PV and storage and expand seamlessly into EV charging or microgrid configurations. This flexibility is critical in addressing capital barriers while ensuring long-term operational continuity. By embedding AI-driven functionalities into its platforms, such as load forecasting, renewable energy optimization, and grid services, Delta enhances resilience, reduces emissions, and enables enterprises to align operations with environmental, social, and governance mandates.

Frost & Sullivan commends Delta for redefining best practices in integrated energy solutions through strategic partnerships, continuous R&D investment, and sustainability leadership. The company’s collaborations across hydrogen energy, EV charging networks, and next-generation power electronics illustrate a robust commitment to building an ecosystem that accelerates the clean energy transition. Its open innovation model and significant reinvestment in research ensure Delta remains at the forefront of addressing evolving customer needs.

Each year, Frost & Sullivan presents the Company of the Year recognition to an organization that demonstrates excellence in growth strategy and execution, innovation, and customer impact. Delta exemplifies these attributes by delivering scalable solutions that transform how businesses and communities generate, store, and consume energy, while advancing Europe’s long-term decarbonization objectives.

Frost & Sullivan Best Practices Recognition
Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact:

Tarini Singh
E: Tarini.Singh@frost.com 

About Delta
Delta, founded in 1971, and listed on the Taiwan Stock Exchange (code:2308), is a global leader in switching power supplies and thermal management products with a thriving portfolio of IoT-based smart energy-saving systems and solutions in the fields of industrial automation, building automation, telecom power, data center infrastructure, EV charging, renewable energy, energy storage and display, to nurture the development of smart manufacturing and sustainable cities. As a world-class corporate citizen guided by its mission statement, “To provide innovative, clean and energy-efficient solutions for a better tomorrow,” Delta leverages its core competence in high-efficiency power electronics and its ESG-embedded business model to address key environmental issues, such as climate change. Delta serves customers through its sales offices, R&D centers and manufacturing facilities spread over close to 200 locations across 5 continents.

Throughout its history, Delta has received various global awards and recognition for its business achievements, innovative technologies and dedication to ESG. Since 2011, Delta has been listed on the Dow Jones Best-in-Class World Index (formerly the DJSI World Index of Dow Jones Sustainability™ Indices) for 14 consecutive years. Delta has also won CDP with double A List for 4 times for its substantial contribution to climate change and water security issues and has been named Supplier Engagement Leader for its continuous development of a sustainable value chain for 8 consecutive years.

Media Contact  
Denise Futterer
Communications Manager, Delta EMEA
denise.futterer@deltaww.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/delta-electronics-receives-frost–sullivans-2025-europe-company-of-the-year-recognition-for-leadership-in-integrated-energy-solutions-302611239.html

SOURCE Frost & Sullivan

Meet Hannah Greenway, a sustainability consultant at Antea Group UK!

  • Office: London
  • Practice Area: Sustainability
  • Area(s) of Expertise: Carbon and ESG
  • About Me in 140 Characters: I am a sustainability consultant helping organisations measure, report & improve performance. I’m passionate about impact and progress.

 

Favourite thing about being a sustainability consultant:

The variety of projects is great. We can work for clients in completely different industries, of different sizes and who have a variety of drivers for wanting to improve their sustainability credentials. Taking your knowledge and confidently applying it in new situations feels very rewarding.

 

What is a key ingredient for success as a sustainability consultant?

Adaptability! Although we work for a variety of clients, we also have to contend with ever-evolving regulations, best practices and scientific knowledge. Research is an important skill to stay up to date.

 

What are some of your favourite tools/resources for professional development in this practice area?

I think learning on the job for a variety of companies is the best way you’ll become a confident sustainability consultant: it helps you apply your knowledge to different contexts, which you’ll never learn on a course. Absorb all the knowledge you can from your colleagues too! ESG-specific news websites can also be useful for keeping track of regulatory changes at a high level, whilst traditional media often have informative climate or sustainability sections that cover science news or interesting exposés on greenwashing!

 

Just for Fun… 

What was your first job?

I worked as banqueting staff for functions, mainly weddings, at a hotel in Sussex when I was 16. It showed me all the behind the scenes stress that comes with getting married!

 

When you were a kid, what did you want to be when you grew up?

Absolutely anything that would’ve worked with animals, although I think my cats’ terrible behaviour at the vets over the years has put me off!

 

What is on the top of your bucket list?

I’d love to see more of the world. I studied geography for my undergraduate degree and I’d love to visit all the volcanoes, mountains and rivers we used as case studies – I think a trip to Iceland is overdue…

 

Bonus – any advice for people looking to go into sustainability consulting?

Start with understanding what drives you. There are so many branches of sustainability – climate adaptation, built environment, circular economy, social value, ESG regulations, carbon reporting, etc – that you need to identify your working style and what you’re passionate about. Are you more of a numbers person? Maybe carbon reporting would suit you, if not, maybe you’d enjoy working with regulations. If you’d like to see a tangible impact you’ve made or you like to get out of the office, then perhaps you’d enjoy the site visits involved in built environment roles.

 

Have any questions?

Contact us to discuss your environment, health, safety, and sustainability needs today.


The European company joins global leaders and experts at the world forum, sharing how its technology contributes to the transition towards a more sustainable energy future

DUBAI, UAE, Nov. 12, 2025 /PRNewswire/ — In November 2025, global leaders will meet in South Africa for the G20 Summit, where one of the key agenda items will be ensuring that the energy transition and sustainable development advance in an achievable way worldwide. The Think 20 (T20), the G20’s policy advisory network, will bring together global experts to address these challenges.

Europe enters the summit with a strong climate policy framework. The European Commission’s strategy towards carbon neutrality has built solid regulatory foundations, yet the region still faces rising energy prices. Households and businesses bear higher bills, a pressing reality in a green transition where progress often lags. This tension between ambition and affordability remains one of Europe’s greatest challenges: ensuring that decarbonisation is economically viable for all.

As noted by the European Commission last October, the processes underpinning this transition are slower than required, limiting the deployment of renewables, the expansion and modernisation of power grids. In response, the Commission has set out seven priority actions to reduce energy costs and streamline permitting for new projects.

Against this backdrop, regulation alone cannot deliver the change required. Technology and innovation have become the true drivers of progress. Real-time monitoring solutions can transform climate targets into measurable results.

Technologies powered by the Internet of Things (IoT) and Artificial Intelligence (AI) are redefining this approach. While achieving a fully renewable energy system within current timelines remains ambitious, the integration of these technologies enables existing infrastructures to be modernised and provides users, households, businesses and municipalities with a clearer understanding of their utility networks, helping them make informed, sustainable decisions.

As global leaders discuss the energy transition in South Africa, SureFlow will showcase how data intelligence can accelerate the G20’s sustainability commitments. The company will feature at G20 South Africa 2025, an official T20 side event, hosting its panel “Smart Cities in Action: Data Intelligence for Sustainable Urban Living.” The session, bringing together participants in Dubai and online from across the world, will showcase live demonstrations and data-led discussions illustrating how AI and IoT are transforming utility management and empowering communities to build smarter, more efficient cities.

With operations in the United Kingdom, across Europe and the United Arab Emirates, SureFlow has established itself as a European leader in technology for energy efficiency. Its AI and IoT-driven systems enable households, businesses and public authorities to monitor and optimise energy consumption in real time, providing scalable and affordable tools that support sustainability commitments.

“Our platform acts as an Intelligent Guardian, detecting anomalies, identifying patterns and guiding users towards more sustainable energy use,” said Sébastien Dui, CEO and Founder of SureFlow.

By turning information into actionable insight, SureFlow helps detect leaks, uncover hidden consumption and address inefficiencies through predictive intelligence. Designed with a do-it-yourself (DIY) approach, its solutions are easy to install and allow rapid, large-scale deployment, while ensuring data privacy and security through advanced encryption and full anonymisation.

As Europe accelerates towards climate neutrality, SureFlow is emerging as a strategic technology partner that makes sustainability tangible.

Photo – https://mma.prnewswire.com/media/2819690/Sureflow_CEO_Sebastien_Dui.jpg
Photo – https://mma.prnewswire.com/media/2819689/Sureflow_Smart_EV.jpg

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/during-t20-south-africa-2025-sureflow-will-join-global-discussions-on-the-role-of-technology-in-the-energy-transition-302612790.html

SOURCE Sureflow

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.